This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

Articles

Safety and Tolerability of the New Antidepressants

J. Craig Nelson, M.D.

Published: March 1, 1997

Article Abstract

The newer serotonergic antidepressants have become popular particularly because of improvedtolerability and safety. The evidence supporting this belief is reviewed. The factors that contribute tothe development of somatic symptoms are examined, including the depression itself and the drugsused for treatment. The rates for individual side effects with the serotonin selective reuptake inhibitors,nefazodone, and venlafaxine are presented and compared with the adverse event experience formirtazapine.


Some JCP and PCC articles are available in PDF format only. Please click the PDF link at the top of this page to access the full text.

Volume: 58

Quick Links: Depression (MDD)

Sign-up to stay
up-to-date today!

SUBSCRIBE

Already registered? Sign In

Case Report

Safety and Tolerability of Concomitant Intranasal Esketamine Treatment With Irreversible, Nonselective MAOIs: A Case Series

Three cases suggest that concomitant use of intranasal esketamine with an irreversible, nonselective MAOI is safe in...

Read More...